Welcome to LookChem.com Sign In|Join Free
  • or
1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

18184-51-5

Post Buying Request

18184-51-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

18184-51-5 Usage

Molecular structure

1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one is a chemical compound with a complex structure that includes a benzochromene core, a hydroxy group, a methyl group, and a piperidine moiety.

Derivative of THC

1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one is a derivative of tetrahydrocannabinol (THC), which is the psychoactive component of cannabis.

Contains a piperidine moiety

The presence of a piperidine group in the structure of 1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one may contribute to its potential therapeutic properties.

Potential therapeutic properties

1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one has been studied for its potential anti-inflammatory and analgesic effects.

Potential treatment for conditions

1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one has shown promise as a potential treatment for conditions such as chronic pain, neuropathic pain, and inflammation.

Potential as an anticancer agent

Further research is needed to determine the potential of 1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one as an anticancer agent.

Ability to modulate the endocannabinoid system

1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one has been investigated for its potential to modulate the endocannabinoid system, which plays a role in various physiological processes.

Development of novel medications

Further research into the pharmacological properties of 1-hydroxy-3-methyl-2-(piperidin-1-ylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one could lead to the development of new medications for a variety of medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 18184-51-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,1,8 and 4 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 18184-51:
(7*1)+(6*8)+(5*1)+(4*8)+(3*4)+(2*5)+(1*1)=115
115 % 10 = 5
So 18184-51-5 is a valid CAS Registry Number.

18184-51-5Downstream Products

18184-51-5Relevant academic research and scientific papers

Modified coumarins. 7. Synthesis and biological activity of mannich bases of substituted 7,8,9,10-tetrahydrobenzo[c]chromen-6-ones

Garazd,Panteleimonova,Garazd,Khilya

, p. 532 - 538 (2002)

Condensation of 1- and 3-hydroxy-7,8,9,10-tetrahydrobenzo[c]chromen-6-ones with substituted 1,1-diaminomethanes produced Mannich bases containing a dialkylaminomethyl group in the 2- and 4-positions of 7, 8,9,10-tetrahydrobenzo[c]chromen-6-one. Pharmacological screening of 2-chloro-3-hydroxy-4-(1-pyrrolidinylmethyl)-7,8,9,10-tetrahydro-6H-benzo[c] chromen-6-one in Wistar rats showed that it possesses low toxicity and acts as a stimulant of the central and peripheral nervous systems with indications of neuroleptic and tranquilizing activities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 18184-51-5